Baguit, Julie Ann S.
HRN: 22-11-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
CEFUROXIME 750MG (VIAL)
10/27/2022
10/29/2022
IV
1.5gm X 6 Doses
Q8
UTI: Asymptomatic Bacteriuria
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No No Infection No Infection
Overall appropriateness: No No Infection